Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT05577169
Other study ID # 15268
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date September 14, 2022
Est. completion date July 7, 2024

Study information

Verified date March 2024
Source Indiana University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Adolescence presents a challenging time for type 1 diabetes management, and despite a multitude of studies aimed at increasing disease compliance in this age group, none have been deemed superior. The purpose of this study is to incorporate mindfulness skills in with diabetes education sessions for adolescents with type 1 diabetes and study if this translates to improved outcomes in glycemic control, patient satisfaction, and mental wellness.


Description:

This is a pilot study to learn if adding mind-body skills to diabetes education is useful in helping adolescents manage their type 1 diabetes. Specifically, the investigators will be studying adolescents aged 15-17 years old with uncontrolled diabetes defined by an A1c >9.0% who have also had the diagnosis of diabetes for at least 12 months. This study combines the teaching of mind-body skills with short virtual diabetes education sessions, in order to address both the direct needs of good diabetes management and the indirect needs of coping with diabetes-related stress and other external factors. The investigators will have two arms of the study - one receiving diabetes education with the addition of mind-body skills, and the other arm receiving only diabetes education. Sessions will be conducted virtually with 20-30 minutes of diabetes education, followed by 20-30 minutes of mind-body skills teaching in the respective arm. The study will consist of 10-12 weekly group sessions, with pre- and post-study questionnaires to evaluate mental and physical health. Participants will continue to attend their regular diabetes clinic appointments every three months. At the end of the study, participants will also partake in a short interview to gather feedback about their experience. The goals of this study are to evaluate the effect of mind-body skills as well as pilot test the feasibility and acceptability of such a project.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 30
Est. completion date July 7, 2024
Est. primary completion date March 5, 2024
Accepts healthy volunteers No
Gender All
Age group 15 Years to 17 Years
Eligibility Inclusion Criteria: - Age 15-17 years - Diagnosis of type 1 diabetes for at least 12 months - Uncontrolled diabetes with A1c at least 9.0% - Parent or guardian agrees for adolescent to participate Exclusion Criteria: - Diagnosed cognitive disabilities - Other uncontrolled chronic diseases as assessed by PI - Inability to attend visits due to individual schedules

Study Design


Intervention

Behavioral:
Mind-body skills
The purpose of mind-body medicine is to use conscious thoughts and actions to positively impact autonomic responses from the brain as well as coping mechanisms for life's stresses. Examples of mind-body skills include deep breathing exercises, meditation, drawing, guided imagery, journaling, affirmations, and biofeedback.
Diabetes education
When children and adolescents are diagnosed with diabetes, education is typically focused on the parents; as our older adolescents prepare to transition to adult care with full responsibility of their health, the goal of short education sessions is to review the basics of T1D along with addressing each individual's needs and questions as they make this transition.

Locations

Country Name City State
United States Indiana University Health Methodist Hospital Indianapolis Indiana
United States Riley Hospital for Children Indianapolis Indiana

Sponsors (2)

Lead Sponsor Collaborator
Indiana University Eli Lilly and Company

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other Patient Health Questionnaire for Adolescents (PHQ-A) Measure of general health and wellbeing. The change in the PHQ-A will be measured from baseline to 12 months. 12 months
Other Screen for Childhood Anxiety Related Emotional Disorders (SCARED-5) questionnaire The change in the SCARED-5 will be measured from baseline to 12 months. 12 months
Other Problem Areas in Diabetes - Teens (PAID-T) questionnaire The change in the PAID-T will be measured from baseline to 12 months. 12 months
Other Peds QL Diabetes Module questionnaire The change in the Peds QL Diabetes Module will be measured from baseline to 12 months. 12 months
Other Mindful Attention Awareness Scale (MAAS) questionnaire for adolescents The change in the MAAS will be measured from baseline to 12 months. 12 months
Other Difficulties in Emotion Regulation Scale (DERS) questionnaire The change in the DERS will be measured from baseline to 12 months. 12 months
Other Child and Adolescent Social Support Scale (CASSS) questionnaire The change in the parent and friends subscales of the CASSS will be measured from baseline to 12 months. 12 months
Primary Feasibility of intervention in the study population. Feasibility of recruitment, retention of participants, and intervention completion. This will be measured by considering study participation rate, time to recruit, attendance, study retention rate, study completion rate, participant burden, and data completeness. 12 months
Primary Acceptability of intervention in the study population. This will be measured by participant satisfaction surveys. 12 months
Secondary Hemoglobin A1c (HbA1c, %) The change in HbA1c will be measured from baseline to 12 months. 12 months
See also
  Status Clinical Trial Phase
Recruiting NCT05653518 - Artificial Pancreas Technology to Reduce Glycemic Variability and Improve Cardiovascular Health in Type 1 Diabetes N/A
Enrolling by invitation NCT05515939 - Evaluating the InPen in Pediatric Type 1 Diabetes
Completed NCT05109520 - Evaluation of Glycemic Control and Quality of Life in Adults With Type 1 Diabetes During Continuous Glucose Monitoring When Switching to Insulin Glargine 300 U/mL
Recruiting NCT04016987 - Automated Structured Education Based on an App and AI in Chinese Patients With Type 1 Diabetes N/A
Active, not recruiting NCT04190368 - Team Clinic: Virtual Expansion of an Innovative Multi-Disciplinary Care Model for Adolescents and Young Adults With Type 1 Diabetes N/A
Recruiting NCT05413005 - Efficacy of Extracorporeal Photopheresis (ECP) in the Treatment of Type 1 Diabetes Mellitus Early Phase 1
Active, not recruiting NCT04668612 - Dual-wave Boluses in Children With Type 1 Diabetes Insulin Boluses in Children With Type 1 Diabetes N/A
Completed NCT02837094 - Enhanced Epidermal Antigen Specific Immunotherapy Trial -1 Phase 1
Recruiting NCT05414409 - The Gut Microbiome in Type 1 Diabetes and Mechanism of Metformin Action Phase 2
Recruiting NCT05670366 - The Integration of Physical Activity Into the Clinical Decision Process of People With Type 1 Diabetes N/A
Active, not recruiting NCT05418699 - Real-life Data From Diabetic Patients on Closed-loop Pumps
Completed NCT04084171 - Safety of Artificial Pancreas Therapy in Preschoolers, Age 2-6 N/A
Recruiting NCT06144554 - Post Market Registry for the Omnipod 5 System in Children and Adults With Type 1 Diabetes
Recruiting NCT05153070 - Ciclosporin Followed by Low-dose IL-2 in Patients With Recently Diagnosed Type 1 Diabetes Phase 2
Recruiting NCT05379686 - Low-Dose Glucagon and Advanced Hybrid Closed-Loop System for Prevention of Exercise-Induced Hypoglycaemia in People With Type 1 Diabetes N/A
Completed NCT05281614 - Immune Effects of Vedolizumab With or Without Anti-TNF Pre-treatment in T1D Early Phase 1
Withdrawn NCT04259775 - Guided User-initiated Insulin Dose Enhancements (GUIDE) to Improve Outcomes for Youth With Type 1 Diabetes N/A
Active, not recruiting NCT01600924 - Study on the Assessment of Determinants of Muscle and Bone Strength Abnormalities in Diabetes
Completed NCT02855307 - Closed-loop Control of Glucose Levels (Artificial Pancreas) During Postprandial Exercise in Adults With Type 1 Diabetes Phase 2
Completed NCT02897557 - Insulet Artificial Pancreas Early Feasibility Study N/A